Mostrar el registro sencillo del ítem

dc.contributor.authorAnarte-Ortiz, Maria Teresa 
dc.contributor.authorCarreira, Mónica
dc.contributor.authorGonzález-Álvarez, Maria Luz
dc.contributor.authorColomo Rodríguez, Natalia
dc.contributor.authorDomínguez-López, Marta
dc.contributor.authorMachado, Alberto
dc.contributor.authorEsteva de Antonio, Maria Isabel
dc.contributor.authorValdés, Sergio
dc.contributor.authorTapia, Maria José
dc.contributor.authorSánchez, Isabel
dc.contributor.authorGuerrero, Mercedes
dc.contributor.authorOlveira, Gabriel
dc.contributor.authorRuiz de Adana, Maria Soledad
dc.date.accessioned2015-04-21T12:19:49Z
dc.date.available2015-04-21T12:19:49Z
dc.date.created2015
dc.date.issued2015-04-21
dc.identifier.urihttp://hdl.handle.net/10630/9675
dc.descriptionThe Psychosocial Aspects of Diabetes (PSAD) Study Group is an official Study Group of the European Association for the Study of Diabetes (EASD).es_ES
dc.description.abstractAIMS: Evidences of benefits of telemedicine in T1DM patients on continuous subcutaneous insulin infusion (CSII) treatment are limited. Aims: 1) to analyse the differences in clinical and psychological variables between subjects with T1DM on CSII treatment who were included in a Telecare (TC) program, and subjects with T1DM on CSII treatment who received Conventional care (CC); 2) Perform a cost analysis of the use of telemedicine in DM1 patients treated with CSII (TC versus CC). METHODS and PARTICIPANTS: Cross-over randomized clinical trial with duration of 18 months. 51 patients signed informed consent. Participants were randomly assigned to receive TC program or CC during 6 months, and after a 3 months wash-out period, patients changed to CC or to TC respectively. TC program included monthly visits using an Internet platform. CC comprised face-to-face visits every three months. Sociodemographic, clinical and psychological data was measured at the beginning and at the end of TC and CC. The direct and indirect costs were also measured. T Student was performed to assess differences between first and last visits in both groups (TC / CC). RESULTS: Patients with telemedicine at the end of treatment, have fewer hyperglycemia / week, less distress and greater adherence. Considering both direct and indirect costs, the cost per treatment (TC / CC) is similar. CONCLUSIONS: Telemedicine has significant implications for clinical and psychological variables and has the same cost (total) than the conventional treatment. Therefore, it can be a useful alternative for treatment of DM1 patients with CSII. However, studies with a larger sample size are needed.es_ES
dc.description.sponsorshipUniversidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.es_ES
dc.language.isoenges_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectTelemedicinaes_ES
dc.subject.otherTelemedicinees_ES
dc.subject.otherPsychologyes_ES
dc.subject.otherDiabeteses_ES
dc.subject.otherSubcutaneous Continuos Insulin Infusion CSIIes_ES
dc.subject.otherCost analysises_ES
dc.titleTelemedicine, Psychology and Diabetes: Evaluation of results and cost analysises_ES
dc.typeinfo:eu-repo/semantics/conferenceObjectes_ES
dc.typeinfo:eu-repo/semantics/otheres_ES
dc.centroFacultad de Psicologíaes_ES
dc.relation.eventtitle20th PSAD Spring Scientific Meetinges_ES
dc.relation.eventplaceMalmö (Sweden)es_ES
dc.relation.eventdateAbril 2015es_ES
dc.identifier.orcidhttp://orcid.org/0000-0002-3730-4644es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem